Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID05452031

A Dyadic Approach to Improve Sleep and Well-Being Among Persons With Alzheimer's Disease and Their Caregivers

Led by University of California, Los Angeles · Updated on 2025-03-26

672

Participants Needed

3

Research Sites

13 weeks

Total Duration

On this page

Sponsors

U

University of California, Los Angeles

Lead Sponsor

U

University of California, San Diego

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness of the Care2Sleep behavioral sleep intervention program for people with Alzheimer's disease or related dementias and their caregivers. This randomized controlled trial lasts 5 years and focuses on improving sleep quality, health status, quality of life for both patients and caregivers, and inflammation levels in caregivers. The study uses Stage II of the NIH behavioral intervention development model to assess these effects. Participants will be assigned randomly to one of three groups: in-person Care2Sleep, telehealth Care2Sleep, or an in-person education control group. Both Care2Sleep programs involve manual-based sleep hygiene recommendations, behavioral sleep intervention, and sleep compression therapy, delivered in five sessions. The education control group receives general information on sleep, aging, and dementia without personalized recommendations. The intervention and control programs start after baseline assessments and randomization. Participants will complete assessments immediately after the last session and again at 6 months to measure sleep efficiency and Pittsburgh Sleep Quality Index scores. Other evaluations include memory and behavior problems, quality of life, caregiver burden, depression, global health, and inflammatory markers. Safety and adherence are monitored, and the total participation duration spans from baseline through a 6-month follow-up.

CONDITIONS

Brief Title

A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a diagnosis of Alzheimer's disease (probable or possible) or related dementia documented in medical records
  • Live in the community (not bedbound)
  • Experience more than one sleep problem at least three times per week
  • Aged over 60 years
  • No untreated sleep disorders such as sleep apnea or restless legs syndrome
  • Able to walk with or without assistive devices
  • No severe medical conditions with life expectancy under 6 months
  • Have an eligible caregiver
  • Caregivers must live with the patient
  • Caregivers aged over 18 years
  • Caregivers related as family, significant other, or friend
  • Caregivers assist patient regularly with daily living activities for at least 6 months
  • Caregivers have a Pittsburgh Sleep Quality Index score over 5
  • Caregivers have a Montreal Cognitive Assessment score of 23 or higher
  • Caregivers can communicate in English
Not Eligible

You will not qualify if you...

  • Patients who are bedbound or have severe medical conditions with life expectancy under 6 months
  • Paid professional caregivers
  • Dyads where either patient or caregiver do not meet eligibility criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - Duration of the intervention period (not explicitly stated)

Participants undergo a behavioral sleep program or receive sleep education to improve sleep and well-being.

Multiple visits depending on intervention assignment (in-person or telehealth)

Follow-up

Duration - 6 months after intervention ends

Participants are assessed immediately and 6 months after the last session of the intervention for sleep quality, behavior, quality of life, caregiver burden, depression, global health, and inflammatory markers.

2 visits (in-person or telehealth)

Trial Site Locations

Total: 3 locations

1

University of California San Diego

La Jolla, California, United States, 92093

Actively Recruiting

2

University of California Los Angeles

Los Angeles, California, United States, 90095

Actively Recruiting

3

Veterans Affairs Greater Los Angeles Healthcare System

Los Angeles, California, United States, 91343

Actively Recruiting

Loading map...

Research Team

Y

Yeonsu Song

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

3

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here